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Abstract
Introduction: Medical problems are frequently encountered during electronic dance music
(EDM) events.
Problem: There are uncertainties about the frequencies and severity of intoxications with
different types of recreational drugs: ethanol, “classical” illicit party drugs, and new
psychoactive substances (NPS).
Methods: Statistical data on the medical problems encountered during two editions of an
indoor electronic dance event with around 30,000 attendants were retrieved from the
Belgian Red Cross (Mechelen, Belgium) database. Data on drug use were prospectively
collected from the patient (or a bystander), the clinical presentation, and/or toxicological
screening.
Results: In the on-site medical station, 487 patients were treated (265 in 2013 and 222 in
2014). The most frequent reasons were trauma (n=171), headache (n= 36), gastro-intestinal
problems (n= 44), and intoxication (n= 160). Sixty-nine patients were transferred to a
hospital, including 53 with severe drug-related symptoms. Analysis of blood samples from 106
intoxicated patients detected ethanol in 91.5%, 3,4-methylenedioxymethamphetamine
(MDMA) in 34.0%, cannabis in 30.2%, cocaine in 7.5%, amphetamine in 2.8%, and
gamma-hydroxybutyric acid (GHB) in 0.9% of patients (alone or in combination). In only six
of the MDMA-positive cases, MDMA was the sole substance found. In 2014, the neuro-
leptic drug clozapine was found in three cases and ketamine in one. Additional analyses for
NPS were performed in 20 cases. Only in one agitated patient, the psychedelic phenethyla-
mines 25B-NBOMe and 25C-NBOMe were found.
Conclusions: At this particular event, recreational drug abuse necessitated on-site medical
treatment in one out of 350 attendants and a hospital transfer in one out of 1,000. Ethanol
remains the most frequently abused (legal) drug, yet classical illicit recreational drugs are
also frequently (co-) ingested. The most worrying observation was high-risk poly-drug use,
especially among MDMA users. Regarding NPS, the number of cases was low and the
clinical presentations were rather mild. It should be stressed that these observations only
apply to this particular event and cannot be generalized to other EDM events.
Calle P, Sundahl N, Maudens K, Wille SMR, Van Sassenbroeck D, De Graeve K,
Gogaert S, De Paepe P, Devriese D, Arno G, Blanckaert P. Medical emergencies
related to ethanol and illicit drugs at an annual, nocturnal, indoor, electronic dance
music event.
Introduction
Many reports suggest that electronic dance music (EDM) events and illicit drug use are
tightly connected, with a high prevalence of 3,4-methylenedioxymethamphetamine
(MDMA), cocaine, amphetamine, cannabis, gamma-hydroxybutyric acid (GHB), and
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ketamine ingestion.1–3 This phenomenon is worrisome as these
substances, known as “party drugs,” “recreational drugs,” or “club
drugs,” have been shown to cause serious health hazards and
death.3–8
The last few years, this important health care issue is further
being complicated by a steadily increasing number of new
psychoactive substances (NPS), also called “research chemicals”
and “designer drugs.” Across the European Union, over 560 NPS
are monitored, with 98 appearing for the ﬁrst time in 2015.9
For most NPS, little knowledge regarding pharmacology and
toxicology is available to users and caregivers, thereby contributing
to major health problems, including fatalities.10–13 Additionally,
ethanol consumption remains a huge problem in Europe. A 31.2%
prevalence of heavy episodic ethanol drinking is found among
youngsters (15-19 years of age), and the proportion of deaths
attributable to ethanol is around 20.0% in the 15-19 years old age
group and around 25.0% in the 20-29 years old age group.14
The main purpose of this prospective study was to describe the
medical problems at the 2013 and 2014 editions of I LOVE
TECHNO (ILT; Ghent, Belgium), one of Europe’s largest
indoor EDM events. Focus was put on the impact of different
types of recreational drugs: ethanol, “classical” illegal party drugs,
and NPS. The results may assist medical caregivers and police
forces in developing prevention strategies at large EDM events,
and to optimize the on-site care.
Methods
Preventive Measures and On-Site Medical Support
The concept of the ILT event and the on-site medical care has
been described previously.6 Brieﬂy, ﬁrst-aid Belgian Red Cross
(Mechelen, Belgium) personnel, reinforced with ﬁve emergency
physicians and six emergency nurses, treated less-serious illnesses
and casualties in the medical station. If necessary, medical stabi-
lization was started on-site, with subsequent transfer to one
of the four nearby participating hospitals by one of the six stand-by
ambulances.
Data Collection
As already described for the 2001 edition, all patients were
registered by the Red Cross, and a standardized registration
form with administrative and medical items was ﬁlled out by the
caregivers.6,15 All apparently intoxicated patients judged by
the attending physician to be in need of an intravenous line
(for example, for the administration of benzodiazepines or ﬂuids)
were included in the toxicology study (irrespective of the patient’s
age and the clinical presentation). For this sub-group, medical
students prospectively recorded the clinical ﬁndings throughout
the patient’s stay in the medical station. Information about the
nature of the ingested substances was gathered from the patient,
accompanying persons, and/or a body search. According to the
protocol, blood samples for toxicological analysis were collected on
the occasion of the vein cannulation. In case of micturition in the
medical station, urine samples were also preserved. For patients
transferred to a hospital, follow-up data were obtained retro-
spectively from the hospital charts. In these patients, urine samples
were also collected. Patients for whom the drug assay proved to be
negative were ultimately excluded from the toxicology study.
The study with an opting-out design was approved by the ethical
committees of the four participating hospitals (University Hospital
Ghent, General Hospital Jan Palﬁjn Ghent, General Hospital Saint
Lucas Ghent, and General Hospital Maria Middelares Ghent;
Belgium). The registration numbers are B670201318873 (for ILT
2013) and B670201422530 (for ILT 2014). The option-out design
implied that blood and urine samples were obtained without
consent. All included patients were given an information letter
(eg, put in a plastic bag together with a cell phone and a wallet for
a comatose patient transferred to a hospital). In this letter, the
included attendants were invited to contact the principal investi-
gator in order to obtain more information on the study and/or to
express their will to be excluded from the study.
Drug Assay
For the toxicology study, all blood and urine samples were subjected
to a standard systematic toxicological screening. Ethanol con-
centration was determined using headspace gas chromatographic-
ﬂame ionization detection. For urine and blood, the following were
applied: gas chromatography-mass spectrometry (GC-MS)method,
with commercially available libraries and high-performance liquid
chromatographic (HPLC) method, combined with a diode-array
detector (Agilent Technologies; Santa Clara, California USA) with
an in-house developed library. Advanced toxicological analysis, such
as LC-MS/MS, GC-MS, or GC-MS/MS, was performed for
quantiﬁcation of Δ9-tetrahydrocannabinol (THC) and its metabo-
lites, cocaine, opioids, GHB, amphetamines, as well as benzodia-
zepines.16–19 For NPS detection and conﬁrmation, commercially
available MS libraries and LC-high-resolution tandem MS with an
in-house developed library were used. The in-house target list
comprised NPS from the following groups: cannabinoids, cath-
inones, phenylethylamines, piperazines, and tryptamines.20
Additional Toxicological Analyses for the NPS Sub-Study
The initial toxicological screening for ethanol, THC, GHB,
cocaine, and amphetamines was performed by trained toxico-
logists who were blinded regarding clinical presentation and
the drug(s) ingested. The results of the toxicology study were
independently cross-referenced with all available clinical data by
two emergency physicians with special interest in party drugs.
Whenever these two experts agreed on a discrepancy between the
clinical and toxicological data, further toxicological analysis was
requested. At this stage of the additional NPS sub-study,
toxicologists were informed about the presenting symptoms. Only
when advanced analysis yielded negative results, blinding
was removed and information pointing to a particular drug
(eg, conviction of mescaline ingestion) was revealed.
Results
The EDM event was attended by 30,000 and 26,000 people in
2013 and 2014, respectively.
A diagram of the studied populations is given in Figure 1.
The number of patients treated in the on-site medical station
was 265 (88.3 per 10,000) in 2013 and 222 (85.4 per 10,000) in
2014. Among these patients, 38 were transferred to a hospital in
2013 (12.7 per 10,000) and 31 in 2014 (11.9 per 10,000).
Details regarding medical problems not related to alcohol or
illicit drugs are presented in Table 1. Of particular interest were
multiple robbery attempts with tear gas in 2014 (leading to 23
victims, including four transferred to a hospital).
The number of patients with drug-related problems was 89 in
2013 (29.6/10,000) and 71 in 2014 (27.3/10,000). The presenting
symptoms are shown in Table 2. Hypoglycemia was excluded in all
these patients. Only one agitated patient was hyperthermic, and
one bradypnoeic patient was intubated endotracheally (Table 3).
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All patients admitted to a hospital were discharged within
18 hours.
According to the study protocol, blood samples were collected
in 113 apparently intoxicated patients (67 in 2013 and 46 in
2014). None of these 113 patients asked to be excluded from the
study. After review of the clinical data and based on negative
toxicology, seven cases initially included in the toxicology study
(six in 2013 and one in 2014) were excluded from the group with
drug-related problems (and subsequently added to the cases not
related to ethanol or illicit drugs). Fifty of the 106 cases included in
the toxicology study (29/61 in 2013 and 21/45 in 2014) were
transferred to a hospital.
For the 56 patients discharged from the on-site medical station
after treatment, analytical toxicology revealed only ethanol in 31
patients (mean 2.0 g/L; range from 0.9 to 2.8 g/L). Three patients
had consumed only MDMA (range: 464-609 ng/mL), and a
further 13 patients had consumed both cannabis and ethanol
(with ethanol concentrations between 0.3 and 2.4 g/L, and
THC concentrations between 0.5 and 7.0 ng/mL). Among the
50 patients transferred to a hospital, only ethanol was found in
16 patients (mean 2.6 g/L; range from 1.9 to 4.0 g/L), only
MDMA in three patients (range: 238-356 ng/mL), and a com-
bination of ethanol and THC in four patients (with ethanol
concentrations between 0.9 and 3.0 g/L and THC concentrations
between 0.5 and 2.9 ng/mL).
For the remaining 36 cases (ie, 27 transferred to a hospital and
nine discharged from the on-site medical station), clinical and
toxicological data (except the ﬁndings on NPS) are shown in
Table 3 and Table 4. Intriguing was the patient transferred to a
hospital with a presumed NPS intoxication. Also of particular
interest were three patients where an intoxication with clozapine
(a neuroleptic drug) was found; these intoxications most likely
resulted from clozapine tablets sold as ecstasy during the event.21
An alternative presentation of the above-mentioned data from
the 106 cases in the toxicology study (but without the results of the
additional NPS sub-study) revealed ethanol in 97 patients
(91.5%), MDMA in 36 (34.0%), THC in 32 (30.2%), cocaine in
eight (7.5%), amphetamine in three and clozapine in three (2.8%),
and ketamine in one and GHB in one (0.9%).
In 20 cases (nine in 2013 and 11 in 2014), the two clinicians
requested additional toxicological analysis. The reasons for the
inclusion in this NPS sub-study (ie, a presumed discrepancy
between clinical data and the ﬁrst set of toxicological data) were:
discrepancy between level of depressed consciousness and
toxicology (n= 8), discrepancy between level of agitation and
toxicology (n= 3), and information on the intake of a particular
drug not detected (n= 9; MDMA in three cases, lysergic acid
diethylamide in two cases, and four individuals assumed having
ingested respectively mescaline, ketamine, a spiced drink, and
sugar cubes impregnated with a drug causing convulsions).
This stepwise toxicological approach revealed the presence of
hallucinogenic phenethylamine derivatives 25B-NBOMe and
25C-NBOMe, in combination with ethanol (0.9 g/L) and THC
(0.8 ng/mL), in an agitated patient. Particularly intriguing in this
NPS sub-study was one patient who remained comatose for more
than one hour with negative toxicology. As no cause for the
depressed level of consciousness was detected during a 6-hour
hospital stay, this case remained in the group of intoxicated
patients (under the assumption that an NPS was ingested that was
not present in the toxicological spectral libraries used for NPS
identiﬁcation).
The toxicological analysis of the urine samples (available in
only 27 of the 106 included cases) provided no additional
information.
Discussion
The ﬁndings in this study on the total number of treated patients,
the number of patients transferred to a hospital after ﬁrst assess-
ment and treatment in the on-site medical station, and the
numbers of patients with potentially life-threatening conditions
(such as coma or convulsions) conﬁrm the need of on-site,
well-organized medical coverage during EDM events, mainly for
incidents related to ethanol and/or illicit drug consumption.5–8
Indirectly, reports on dead party goers from other EDM events
strongly suggest that Advanced Life Support providers in the ﬁeld
may save lives. Without any doubt, the deployment of medical
teams at EDM events avoids many transfers to a hospital.5–8,22–25
Main Findings in the Intoxicated Patients from this Study
The toxicology data in the present study revealed that the most
prevalent substance used was ethanol: in up to 91.5% (97/106)
ethanol was found, with ethanol being the only substance detected
in 47.4% (46/97). Another ﬁgure underscoring the dominant role
of ethanol was the 90.0% (45/50) prevalence of ethanol use in
56,000 attendants
487 patients treated in
on-site medical station
327 cases not related to ethanol or
illicit drugs (including 16 patients
transferred to a hospital +
including 7 patients initially
included in the toxicology study,
but ultimately excluded because
of negative toxicological
screening)
160 cases related to ethanol or
illicit drugs (including 53
patients transferred to a hospital)
54 intoxicated patients judged not
to be in need of an intravenous line
(including 3 patients transferred to
a hospital)
106 patients included in the
toxicology study (i.e. all intoxicated
patients judged to be in need of
an intravenous line)
50 patients transferred to a hospital
- only ethanol : 16
- only MDMA : 3
- only NPS : 1*
- ethanol + THC :4
- other multi-drug use : 26
(see Table 3)
56 patients discharged from the
on-site medical station
- only ethanol : 31
- only MDMA : 3
- ethanol + THC : 13
- other multi-drug use : 9
(see Table 4)
Calle © 2017 Prehospital and Disaster Medicine
Figure 1. Diagram of Study Populations.
Abbreviations: MDMA, 3,4-methylenedioxymethamphetamine;
NPS, new psychoactive substances; THC, tetrahydrocannabinol.
* The toxicological screening in a patient remaining comatose for
more than one hour was negative; this case is described in more
detail in the sub-study on new psychoactive substances (NPS).
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patients transferred to a hospital, with ethanol being the only
substance in 35.6% (16/45).
Second, among the “classic” illicit party drugs, only
MDMA (34.0%) and cannabis (30.2%) were frequently detected.
Worrisome is the observed poly-drug use in MDMA-positive
cases. In only six cases, MDMA was the sole substance found
(with concentrations between 238 and 609 ng/mL). Among the
other 30 MDMA users, ethanol was most prevalent (found in 29
patients), followed by THC (11 patients), cocaine (six patients),
and amphetamine (two patients). Most perturbing were the
six cases with MDMA concentrations above 800 ng/mL in
combination with ethanol levels of at least 1.7 g/L (plus cocaine
use in three).
Third, with regard to the use of GHB, ketamine, and all
categories of NPS, the number of positive cases was low and the
clinical presentations were rather mild.
A fourth point of interest was the discrepancy between
toxicological data and the information provided concerning
the ingested substance(s). There were seven cases where the
presumed consumed drug was not found. Also, the three
patients intoxicated with clozapine (assumed to be sold as
ecstasy) were very remarkable. As this study was not designed
to investigate this issue, these 10 cases were certainly an
under-estimation. The dangers associated with this pheno-
menon were shown clearly by the clozapine case in need of
intubation.10,11,21
What are the Implications of the Above-Mentioned
Toxicological Results?
In view of the time needed to perform all analyses, it is obvious that
the patients and the treating physicians do not beneﬁt from this
laborious and costly research. Moreover, the therapy for all party
drugs, including all known NPS, is symptom-driven (and not
substance-speciﬁc or dose-dependent). Consequently, even point-
of-care testing (if ever available) would rarely alter clinical decision
making nor therapy.3,4 Therefore, the surplus value of this type
of toxicological research involves mainly epidemiology and case
histories (eg, the high-risk behavior of many MDMA users and
the clozapine trickery), with the remark that extrapolating data
from one event to another is troublesome. Nevertheless, up-
to-date information on locally available party drugs (including
dosage, color and logo on pills, contaminants, forgeries, and
unusual clinical presentation) is important for potential users,
medical caregivers, police forces, and political decision makers. For
that purpose, scrutinized data from research projects performed
during a particular event are useful, but only when combined with
repetitive and wide-ranging surveys on drug use, a continuous
program for in-depth chemical analysis on seized materials, and a
nation-wide network of Emergency Medical Services, hospitals,
and coroners collecting clinical and toxicological data.9–12,26
The above-mentioned line of thought leads inevitably to the
importance of all kinds of preventive measures: information and
warnings to the attendants, close cooperation between the
organizing committee and the law enforcement authorities to limit
the on-site availability of illicit drugs, early detection and
appropriate protective measures towards inebriated or intoxicated
attendants, the on-site presence of properly trained and equipped
medical care providers, and legal actions to classify NPS as illicit
drugs. Whether or not pill testing/drug checking projects acces-
sible for lay persons are valuable is a matter of (political/ethical)
debate.27 To some extent, these preventive measures on a parti-
cular EDM may be tailored by the results of locally performed
toxicological studies.
Limitations
Some limitations of this study should be stressed.
First, the cases described were subject to selection bias
regarding at least ﬁve items. The decision to bring a patient to the
on-site medical station depended on many non-medical factors
such as the attitude of friends/bystanders and the vigilance of
stewards. Furthermore, the classiﬁcation as a drug-related event,
2013 2014
Coma 7 (5) 3 (3)
Agitation/Anxiety 19 (13) 17 (12)
Convulsions 6 (5) 1 (1)
Syncope 9 (1) 10 (1)
Vomiting/Abdominal Pain 13 10
Chest Pain/Palpitations 4 (1) 1
Inebriety 29 (5) 23 (6)
Headache 2 5
Hallucinations — 1
Total 89 (30) 71 (23)
Calle © 2017 Prehospital and Disaster Medicine
Table 2. Presenting Symptoms Related to Ethanol or
Illicit Drugs
Note: The number of patients transferred to a hospital is
shown between brackets.
2013 2014
Trauma 86 (5) 85 (7)
Malaise, Vertigo 12 6
Headache 19 17
Abdominal Pain, Vomiting 24 (2) 20
Syncope 6 —
Convulsions 2 (1) —
Psychogenic Hyperventilation 2 —
Chest Pain 1 1
Others 21 18 (1)
Unknown 3 4
Total 176 (8) 151 (8)
Calle © 2017 Prehospital and Disaster Medicine
Table 1. Presenting Symptoms Not Related to Ethanol or
Illicit Drugs
Note: The number of patients transferred to a hospital is
shown between brackets.
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the instruction to insert an intravenous line (ie, the starting point
for the inclusion in the intoxication study), and the decision to
hospital transfer may vary from one emergency physician to
another, especially because most decisions were taken under
pressure within a short period of time and/or without sufﬁcient
information. In addition, the request for an additional NPS
toxicological analysis was impossible to standardize and therefore
also bias-prone. Some examples of the (almost inevitable) risk of
selection bias in this study are the seven cases initially included in
the toxicology study (eg, because of syncope or convulsions) but
subsequently excluded as toxicology was negative, the three cases
that were included but could be discharged from the on-site
medical station within 30 minutes (Table 4), and the intriguing
case from the NPS sub-study remaining comatose for more than
one hour with negative toxicology.
Second, important pieces of information were lacking or unre-
liable for many patients, despite the on-site presence of medical
students having no other task than collecting and registering data.
Third, toxicologists can never be 100% sure about the absence
of illicit drugs since many substances (especially NPS) are active at
very low concentrations. Moreover, the number of NPS is
seemingly unending.9–11 This issue is perfectly illustrated by
the 25B-NBOMe/25C-NBOMe case. These NPS were only
detected during the third toxicological search, and necessitated
the use of innovative equipment and techniques.13,20
It is important to mention that the above-mentioned methodo-
logical limitations are practically inescapable and that very
few studies collected toxicological data as rigorously as in the
present study. Indeed, other studies only analyzed data collected
Toxicological Findings (Only Blood
Samples) Presenting Symptoms
Ethanol 0.9 g/L +MDMA 210 ng/mL Agitation
Ethanol 2.1 g/L +MDMA 472 ng/mL Agitation
Ethanol 0.3 g/L +MDMA 575 ng/mL Agitation
Ethanol 2.3 g/L +MDMA 253 ng/mL Convulsions
Ethanol 0.7 g/L +MDMA 492 ng/mL Agitation
Ethanol 2.2 g/L +MDMA 417 ng/mL Agitation
Ethanol 1.9 g/L +MDMA 619 ng/mL Agitation
Ethanol 2.0 g/L +MDMA 927 ng/mL Agitation
Ethanol 2.6 g/L +MDMA 480 ng/mL Agitation
Ethanol 1.7 g/L +MDMA 833 ng/mL Agitation
Ethanol 2.5 g/L +MDMA 650 ng/mL
+THC 3.6 ng/mL
Agitation
Ethanol 2.3 g/L +MDMA 480 ng/mL
+THC 2.3 ng/mL
Convulsions
Ethanol 0.8 g/L +MDMA 160 ng/mL
+THC 2.0 ng/mL
Agitation
Ethanol 1.9 g/L +MDMA 78 ng/mL
+THC 1.9 ng/mL
Syncope
Ethanol 1.7 g/L +MDMA 166 ng/mL
+THC 8.7 ng/mL
Chest Pain
Ethanol 1.1 g/L +MDMA 690 ng/mL
+THC 0.7 ng/mL
Agitation
Ethanol 2.3 g/L+MDMA 1,510ng/mL
+THC 0.6ng/mL
Agitation
Ethanol 2.8 g/L +MDMA 876 ng/mL
+BE 614 ng/mL
Agitation
Ethanol 2.0 g/L +MDMA 956 ng/mL
+BE 180 ng/mL
Agitation
Ethanol 2.2 g/L+MDMA 1,178ng/mL
+BE 124ng/mL
Agitation +Hyperthermia
Ethanol 0.9 g/L + amphetamine 155ng/
mL+GHB 257 µg/mL
Agitation
Ethanol 1.9 g/L +MDMA 434 ng/
mL+ amphetamine 64 ng/mL+THC
0.6 ng/mL
Agitation
Ethanol 1.5 g/L +MDMA 646 ng/mL
+BE 444 ng/mL+THC 9.2 ng/mL
Agitation
Ethanol 1.1 g/L + clozapine 243 ng/mLa Agitation
Ethanol 0.7 g/L + clozapine 95 ng/
mL+MDMA 635 ng/mL
Agitation
BE 182ng/mL+MDMA 167ng/mL+
amphetamine 10ng/mL+THC 2.7ng/mL
Convulsions
Calle © 2017 Prehospital and Disaster Medicine
Table 3. Clinical and Toxicological Findings in 26 Cases
Transferred to a Hospital because of Multi-Drug Use (with the
exception of the combination of ethanol and cannabis)
Abbreviations: MDMA, 3,4-methylenedioxymethamphetamine;
THC, tetrahydrocannabinol; GHB, gamma-hydroxybutyric acid;
BE, benzoylecgonine (ie, the main metabolite of cocaine).
a This case was intubated three hours after transfer to the hospital
because of recurrent episodes of bradypnea.
Toxicological Findings (Only
Blood Samples)
Presenting
Symptoms
Length-
of-Stay
in Medical
Station
Ethanol 2.7 g/L +MDMA 478ng/mL Coma 55 min
Ethanol 1.4 g/L +MDMA 210ng/mL Vomiting 24 min
Ethanol 2.2 g/L +MDMA 478ng/mL Agitation 40 min
Ethanol 0.7 g/L +MDMA 399ng/mL Agitation 155 min
Ethanol 1.2 g/L +MDMA 282ng/mL
+THC 4.9 ng/mL
Syncope 19 min
Ethanol 2.2 g/L +MDMA 439ng/mL
+BE 160ng/mL
Hallucinations 115 min
Ethanol 1.3 g/L +BE 135ng/mL
+THC 14ng/mL
Chest pain 55 min
Ethanol 0.7 g/L+clozapine 73ng/mL
+THC 1ng/mL
Syncope 16 min
BE 270 ng/mL+ ketamine 20ng/mL
+THC 2.4 ng/mL
Vomiting 64 min
Calle © 2017 Prehospital and Disaster Medicine
Table 4. Clinical and Toxicological Findings in Nine Patients
Who could be Discharged from the On-Site Medical Station
(with the exception of the combination of ethanol and cannabis)
Abbreviations: MDMA, 3,4-methylenedioxymethamphetamine;
THC, tetrahydrocannabinol; BE, benzoylecgonine (ie, the main
metabolite of cocaine).
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retrospectively (using chart review) or classiﬁed drug use with only
a limited number of toxicological tests, or even without any
toxicological analysis at all.5,7,8,22–25,28 For all these reasons, any
comparison between studies or extrapolation from one music event
to another have to be done with great caution.
Conclusion
The results of the present study conﬁrm the need for on-site,
well-organized medical coverage during EDM events, mainly for
incidents related to ethanol and/or illicit drugs. The most
prevalent substance was ethanol. Most worrying was the high-risk,
poly-drug use, especially among MDMA users where very high
MDMA concentrations were observed. Regarding GHB,
ketamine, and all categories of NPS, the numbers of cases were
low and the clinical presentations rather mild. Extrapolating these
ﬁndings to other events should be done with great caution as each
event has its own particularities and considerable selection bias
inﬂuences data gathering in this kind of study.
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